Name:
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)
Type:
Psychedelic phenethylamine
AKA:
25C-NBOMe, 2C-C-NBOMe, 25C, Cimbi-82
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) image
Synthetic substance, no natural derivative
IUPAC Logo
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) image
25C-NBOMe, a synthetic hallucinogen, was synthesized in the 2010s. It is part of the NBOMe series known for its potent psychedelic effects. Its history includes health risks and regulatory challenges due to its potency and potential for abuse.
Synthetic Substances Image
2-(4-Chloro-2,5-dimethoxyphenyl)-n-(2-methoxybenzyl)ethanamine, or 25C-NBOMe, is a potent hallucinogen. It causes intense visual and sensory distortions, increased heart rate, and dilated pupils. Short-term use leads to profound hallucinations, while long-term use may cause psychological issues. Overdose risks include severe agitation and cardiovascular problems. Safe use involves controlled settings. Recent research explores its effects on perception and potential therapeutic applications.
N/A
25C-NBOMe, a psychedelic, affects serotonin receptors, leading to altered perception and mood enhancement. Immediate effects include euphoria and sensory distortions, lasting several hours. Long-term use may result in persistent psychological effects and altered cognition. Research emphasizes its potency and potential for long-term psychological effects with chronic use.
N/A
25C-NBOMe is a potent synthetic psychedelic that is part of the NBOMe series. Its cultural significance is tied to its use in recreational settings and its potent hallucinogenic effects. Media coverage often addresses the risks associated with its use, including overdose and adverse reactions. 25C-NBOMe is used recreationally rather than medicinally, contributing to discussions about the safety and regulation of synthetic psychedelics.
N/A